Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

BATS BZX Real-Time Price
 +0.19 / +1.44%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Keryx Biopharmaceuticals, Inc. is a biopharmaceutical company. It engages in the acquisition, development and commercialization of pharmaceutical products for the treatment of renal disease. It develops Zerenex, an oral, ferric iron-based compound that has the capacity to bind to phosphate in the gastrointestinal tract and form non-absorbable complexes. The company was founded in October 1998 and is headquartered in New York, NY.

Contact Information

Keryx Biopharmaceuticals, Inc.
750 Lexington Avenue
New York New York 10022
P:(212) 531-5965
Investor Relations:
(212) 531-5962



Other institutional47.10%
Mutual fund holders39.67%
Individual stakeholders16.19%

Top Executives

Ronald BentsurChief Executive Officer & Director
Gregory P. MadisonPresident, Chief Operating Officer & Executive VP
James F. OlivieroCFO, Secretary, Treasurer & CAO
Amit SharmaVice President-Medical Affairs
Douglass H. LaidlawDirector-Medical Affairs

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.